Is IDXX or IMDX more undervalued in 2026?

CirclFi compares IDEXX Laboratories, Inc. (IDXX) and Insight Molecular Diagnostics I (IMDX) using 13 institutional-grade valuation models. IDXX has a Quality of Company score of 10.0/10 while IMDX scores 5.3/10.

Which is a better buy — IDXX or IMDX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do IDXX and IMDX valuations compare?

IDXX at $568.03 and IMDX at $6.53 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

IDXX vs IMDX Valuation Comparison 2026 — Intrinsic Value Analysis

IDXX

Diagnostics & Research

IDEXX Laboratories, Inc.

Quality

10.0

out of 10

Value Trap

SAFE

Price

$568.03

Last close

Models

13/13

Active

IMDX

Diagnostics & Research

Insight Molecular Diagnostics I

Quality

5.3

out of 10

Value Trap

SAFE

Price

$6.53

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	IDXX Fair Value	IDXX Upside	IMDX Fair Value	IMDX Upside
Bayesian DCF	Intrinsic	$201.05	-64.6%	$2.19	-66.5%
Earnings Power Value	Intrinsic	$129.30	-77.2%	$1.19	-71.6%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for IDXX vs IMDX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IDXX vs IMDX — Which Stock Is More Undervalued?

IDXX scores higher with a 10.0/10 quality rating vs IMDX's 5.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing IDEXX Laboratories, Inc. (IDXX) and Insight Molecular Diagnostics I (IMDX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IDXX currently trades at $568.03 with a QOC of 10.0/10, while IMDX trades at $6.53 with a QOC of 5.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).